ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019
Human Immunodeficiency Virus (HIV) Viral Suppression After Transition From Having No Healthcare Coverage and Relying on Ryan White HIV/AIDS Program Support to Medicaid or Private Health Insurance.
Julia Raifman, Keri Althoff, Peter F Rebeiro, W Christopher Mathews, Laura W Cheever, Heather Hauck, Judith A Aberg, Kelly A Gebo, Richard Moore, Stephen A Berry and 1 more
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Julia RaifmanDepartment of Health Law, Policy & Management, Boston University School of Public Health, Massachusetts.
Keri AlthoffDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland.
Peter F RebeiroDepartment of Medicine, Vanderbilt University, Nashville, Tennessee.
W Christopher MathewsOwen Clinic, University of California, San Diego.
Laura W CheeverHIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland.
Heather HauckHIV/AIDS Bureau, Health Resources and Services Administration, Rockville, Maryland.
Judith A AbergDepartment of Infectious Diseases, Mount Sinai Icahn School of Medicine, New York.
Kelly A GeboDepartment of Medicine, John Hopkins University School of Medicine.
Richard MooreDepartment of Medicine, John Hopkins University School of Medicine.
Stephen A BerryDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.
HIV Research Network
Funding
LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Jennifer Jao, Sharon A Nachman · 2011 to 2026
$278.1M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
North American AIDS Cohorts on Collaboration and Design (NAACCORD)U01AI069918 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Keri Nicole Althoff, RICHARD Douglas MOORE · 2006 to 2026
$65.2M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Johns Hopkins Adolescent Medicine Trials UnitU01HD068070 · NICHD · JOHNS HOPKINS UNIVERSITY · PI AGWU, ALLISON L · 2011 to 2015
$1.7M
A Structural Approach to Improving HIV Pre-Exposure Prophylaxis (PrEP) Implementation among High Risk MenK01MH116817 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAIFMAN, JULIA · 2018 to 2021
$639k
The HIV Care Continuum and Health Policy: Changes through Context and GeographyK01AI131895 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI REBEIRO, PETER F · 2017 to 2021
$623k
Evaluating HIV pre-exposure prophylaxis implementation using an all payers claims databaseR21MH113431 · NIMH · MIRIAM HOSPITAL · PI CHAN, PHILIP ANDREW, GALARRAGA, OMAR · 2017 to 2018
Among 1942 persons with human immunodeficiency virus (HIV) without healthcare coverage in 2012-2015, transitioning to Medicaid (adjusted prevalence ratio, 0.95 [0.87, 1.04]) or to private health insurance (1.04 [0.95, 1.13]) was not associated with a change in consistent HIV viral suppression compared to continued reliance on the Ryan White HIV/AIDS Program.
Indexed as
Health Services AccessibilityAdolescentAdultAgedCohort StudiesFemaleHIV InfectionsHumansInsurance CoverageInsurance, HealthMaleMedicaidMiddle AgedPatient Protection and Affordable Care ActUnited StatesViral LoadAffordable Care ActHIVHIV viral suppressioninsuranceMedicaid
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Human Immunodeficiency Virus (HIV) Viral Suppression After Transition From Having No Healthcare Coverage and Relying on Ryan White HIV/AIDS Program Support to Medicaid or Private Health Insurance. · full record | OpenQuestion